TMDX
TransMedics Group, Inc.
-1.16 (-1.32%)86.41USD175K成交股數3.0B市值22.4本益比(近四季)4.5股價營收比+20.7%營收年增(近四季)2026-10-29下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 190M+32% | 174M+43% | 144M+32% | 157M+38% | 144M+48% | 122M+83% | 109M+107% | 114M+175% | 96.9M | 66.4M | 52.5M | 41.6M |
| 營業成本 | 76.8M | 72.8M | 59.2M | 60.8M | 55.3M | 49.6M | 47.9M | 45.0M | 36.9M | 25.8M | 15.7M | 12.8M |
| 毛利 | 113M+28% | 101M+40% | 84.6M+39% | 96.6M+39% | 88.2M+47% | 72.0M+77% | 60.8M+66% | 69.3M+141% | 60.0M | 40.7M | 36.7M | 28.8M |
| 毛利率 | 59.6% | 58.2% | 58.8% | 61.4% | 61.5% | 59.2% | 55.9% | 60.6% | 61.9% | 61.2% | 70.0% | 69.2% |
| 研發費用 | 31.6M | 24.9M | 15.3M | 15.9M | 17.2M | 16.5M | 14.3M | 13.9M | 11.4M | 11.1M | 8.3M | 5.9M |
| 銷售管理費用 | 57.8M | 63.0M | 46.0M | 44.1M | 43.6M | 46.9M | 42.7M | 42.9M | 36.2M | 30.7M | 29.4M | 25.0M |
| 營業利益 | 23.7M-14% | 13.3M+54% | 23.3M+494% | 36.6M+192% | 27.4M+121% | 8.6M-131% | 3.9M-533% | 12.5M-699% | 12.4M | −28.3M | −906K | −2.1M |
| 營業利益率 | 12.5% | 7.6% | 16.2% | 23.2% | 19.1% | 7.1% | 3.6% | 10.9% | 12.8% | -42.7% | -1.7% | -5.0% |
| 稅後淨利 | 14.7M-43% | 7.3M+6% | 24.3M+477% | 34.9M+186% | 25.7M+111% | 6.9M-127% | 4.2M-521% | 12.2M-563% | 12.2M | −25.4M | −1.0M | −2.6M |
| 淨利率 | 7.7% | 4.2% | 16.9% | 22.2% | 17.9% | 5.7% | 3.9% | 10.7% | 12.6% | -38.3% | -1.9% | -6.3% |
| 稀釋 EPS | 0.41-41% | 0.20+5% | 0.66+450% | 0.92+163% | 0.70+100% | 0.19-124% | 0.12-500% | 0.35-538% | 0.35 | -0.78 | -0.03 | -0.08 |
| 稀釋股數 | 40.7M | 36.2M | 40.7M | 40.6M | 39.9M | 35.2M | 35.7M | 35.3M | 34.7M | 32.6M | 32.5M | 32.3M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 491M | 480M | 467M | 401M | 311M | 337M | 330M | 363M | 350M | 427M | 582M | 195M |
| 應收帳款 | 104M | 90.7M | 80.7M | 105M | 142M | 97.7M | 90.1M | 81.2M | 81.9M | 60.7M | 47.5M | 38.6M |
| 存貨 | 54.1M | 49.9M | 44.5M | 38.9M | 43.4M | 46.6M | 52.2M | 48.7M | 48.5M | 39.4M | 30.5M | 24.0M |
| 總資產 | 1.5B | 1.4B | 946M | 891M | 838M | 804M | 786M | 759M | 724M | 689M | 690M | 287M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | 58.8M |
| 總負債 | 946M | 941M | 591M | 572M | 571M | 575M | 576M | 569M | 564M | 563M | 545M | 94.5M |
| 股東權益 | 518M | 494M | 355M | 318M | 266M | 229M | 210M | 190M | 159M | 126M | 145M | 193M |
| 負債比 | 64.6% | 65.6% | 62.5% | 64.3% | 68.2% | 71.6% | 73.3% | 75.0% | 78.0% | 81.7% | 79.0% | 32.9% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | 137M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 24.5M | – | – | −2.9M-17% | – | – | – | −3.4M | – | – | −8.7M |
| 資本支出 | – | 36.7M | – | – | 27.0M | – | – | – | 44.2M | – | – | 927K |
| 自由現金流 | – | −12.1M | – | – | −29.9M-37% | – | – | – | −47.6M | – | – | −9.6M |
| 折舊攤銷 | – | 11.9M | – | – | 6.1M | – | – | – | 4.3M | – | – | 1.3M |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -7.0% | – | – | -20.8% | – | – | – | -49.2% | – | – | -23.1% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 601M
| Ocs Transplant Revenue | 601M | 100.0% | +37.6% |
|---|
產品／服務2025 年度 · 610M
| 產品 | 372M | 61.1% | +36.0% |
|---|---|---|---|
| 服務 | 233M | 38.2% | +39.0% |
| Service Unrelated To OCS Transplant | 4.1M | 0.7% | -6.8% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 605M | +37.1% | 190M | 31.4% | 4.87 | 134M |
| FY2024 | 442M | +82.7% | 35.5M | 8.0% | 1.01 | −80.9M |
| FY2023 | 242M | +158.5% | −25.0M | -10.3% | -0.77 | −165M |
| FY2022 | 93.5M | +197.8% | −36.2M | -38.7% | -1.23 | −57.7M |
| FY2021 | 31.4M | +10.7% | −44.2M | -140.8% | -1.60 | −32.4M |
| FY2020 | 28.4M | +9.7% | −28.7M | -101.4% | -1.16 | −30.7M |
| FY2019 | 25.8M | +76.3% | −33.5M | -129.8% | -2.36 | −32.5M |
| FY2018 | 14.7M | – | −23.8M | -162.1% | -17.48 | −26.4M |